Developer docs
API playgroundTry for free, no card

Search company profiles

Prohibition Partners

Full company profile

uuid000dl16

Namestring
Prohibition Partners
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Prohibition Partners is a London-based, privately held cannabis industry intelligence and events company founded in 2017, operating as a B2B research and media business serving cannabis operators, cultivators, manufacturers, dispensaries, insurers, and healthcare stakeholders across global markets including the UK, Germany, Canada, Australia, Brazil, Portugal, Poland, Thailand, and the Czech Republic. The company's product portfolio centers on the annual Global Medical Cannabis Market Review, which compiles export volumes, patient market sizes, telemedicine adoption, and regulatory developments, and is distributed alongside owned media platforms (Business of Cannabis, Cannabis Health News) that serve as both thought-leadership assets and top-of-funnel distribution channels. In February 2026 the company launched PPX, a full-service growth marketing division providing brand strategy, market entry, PR, and demand generation services to cannabis businesses, leveraging the company's proprietary market data and regulatory advisors to deliver compliant creative work that traditional agencies cannot provide. Revenue is generated through four streams: subscription and recurring intelligence reports, events and conferences (including the Business of Cannabis: New York Summit), PPX professional services engagements, and specialized risk analysis reports produced in partnership with Relm covering insurance challenges in the cannabis sector. Leadership is held by co-founders Stephen Murphy (CEO) and Rob Reid.

Short descriptiontext

Prohibition Partners is a London-based cannabis industry intelligence and events company founded in 2017, publishing market research (Global Medical Cannabis Market Review), operating media platforms (Business of Cannabis, Cannabis Health News), and running PPX growth marketing services for cannabis operators across global markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
cannabis market intelligence, cannabis industry research, cannabis consulting services, cannabis media publishing, cannabis growth marketing
NAICS code1 code
  • Convention and Trade Show Organizers56192
SIC code1 code
  • Miscellaneous Publishing2741
Product category
Cannabis Industry Intelligence and Consulting
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Intelligence Reports and Research
TypeSubscription Recurring
Description

Annual and periodic market intelligence publications covering global medical cannabis markets, trends, and regulatory analysis.

businessofcannabis.com
2Events and Conferences
TypeSubscription Recurring
Description

Industry events including the Business of Cannabis: New York Summit, connecting operators and stakeholders in the cannabis industry.

businessofcannabis.com
3PPX Marketing Services
TypeProfessional Services
Description

Full-service growth marketing division providing brand strategy, market entry, PR, and demand generation services to cannabis businesses.

businessofcannabis.com
4Risk Briefing Partnership Reports
TypeSubscription Recurring
Description

Specialized insurance and risk analysis reports produced in partnership with Relm, targeting cannabis operators and insurers.

businessofcannabis.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Operations, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Business of Cannabis
Description

Media platform covering cannabis industry news and market intelligence.

businessofcannabis.com
+2 more records
Core offering1 text field

Prohibition Partners is a cannabis industry intelligence and events company that publishes market research reports, operates media platforms (Business of Cannabis, Cannabis Health News), and runs industry conferences focused on the legal cannabis sector. It also delivers growth marketing services through its PPX division, combining proprietary market data and regulatory expertise to serve cannabis operators across global markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Canada shipped 275,343kg in 2025, representing over 250% year-on-year growth
+3 more records
Product overview1 text field

Prohibition Partners operates as a cannabis industry intelligence and events company offering a portfolio of products including industry research reports (Global Medical Cannabis Market Review, Risk Briefing), media platforms (Business of Cannabis, Cannabis Health News), and growth marketing services (PPX). The company provides market intelligence, regulatory analysis, and strategic services to cannabis businesses, leveraging its proprietary data and regulatory expertise across multiple markets.

Product and service6 records
1PPX Growth Marketing Division
CategoryMarketing and Consulting Services
Description

Full-service growth marketing division providing brand strategy, market entry, public relations, and demand generation services to cannabis businesses, leveraging proprietary market data and regulatory expertise.

2Global Medical Cannabis Market Review
CategoryResearch and Intelligence Reports
Description

Annual industry intelligence report providing analysis of the global medical cannabis market, including market sizing, trade flows, regulatory developments, and patient access trends across key markets such as Canada, Germany, UK, Australia, Brazil, and Portugal.

3Business of Cannabis
CategoryMedia Platform
Description

Media platform covering cannabis industry news, market analysis, and business intelligence, operated by Prohibition Partners and used as part of the PPX growth marketing ecosystem.

4Cannabis Health News
CategoryMedia Platform
Description

Health-focused media platform covering medical cannabis topics and information, operated by Prohibition Partners as part of its owned media ecosystem.

5Risk Briefing Report
CategoryResearch and Intelligence Reports
Description

Specialized risk management report published in partnership with Relm, providing analysis of insurance challenges, governance practices, EU-GMP certifications, and comprehensive risk controls for cannabis operators and insurers.

6Business of Cannabis Industry Summits and Events
CategoryIndustry Events and Conferences
Description

Industry conferences and summits, including the Business of Cannabis: New York Summit, connecting cannabis operators, investors, and other stakeholders across the global cannabis industry.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Relm to produce Risk Briefing reports analyzing insurance challenges in the cannabis industry. The collaboration resulted in a comprehensive report including interviews with operators such as Glass Pharms, Linnea, SOMAÍ Pharmaceuticals, and PHCANN International. The report addresses governance practices, EU-GMP certifications, and comprehensive risk controls that insurers are demanding from cannabis operators.

Strategic tierCoreTypeOthers
Description

Owned media platform serving as a primary distribution channel for Prohibition Partners' market intelligence and thought leadership. The platform provides news, analysis, and industry coverage supporting the company's intelligence and marketing services.

3Cannabis Health News
Strategic tierCoreTypeOthers
Description

Owned media platform focused on medical cannabis health content. Part of Prohibition Partners' owned media ecosystem that leverages proprietary market data and regulatory advisors to deliver compliant content.

businessofcannabis.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

The Dales Report provides cannabis industry news, research, and educational content targeting operators and investors. It is an emerging peer to Prohibition Partners' Business of Cannabis and Cannabis Health News platforms, with a smaller footprint.

TypeDirect peer
Description

Green Market Report is a cannabis-focused financial and business news outlet covering publicly traded cannabis companies and market trends. It overlaps with Prohibition Partners' intelligence and media offerings for the cannabis investment community.

TypeDirect peer
Description

Cannabis Business Times is a leading B2B trade publication covering cultivation, retail, and regulatory developments in the cannabis industry. It is directly comparable to Prohibition Partners' Business of Cannabis platform in serving cannabis operators with news and analysis.

TypeDirect peer
Description

MJBizDaily is the largest B2B cannabis media and events company in North America, running the flagship MJBizCon expo and a suite of market research reports. It is directly comparable to Prohibition Partners as a cannabis-focused intelligence, media, and events franchise serving operators.

TypeBroad incumbent
Description

Weedmaps is a publicly traded cannabis marketplace and SaaS platform serving retailers and brands with listings, advertising, and data. It overlaps with Prohibition Partners' PPX marketing services and intelligence offerings but is a larger, more diversified incumbent.

TypeBroad incumbent
Description

Benzinga is a broader financial media company with a dedicated cannabis vertical covering market moves, M&A, and policy. It overlaps with Prohibition Partners' intelligence reporting for cannabis investors but operates at a much larger, more diversified scale.

TypeBroad incumbent
Description

Leafly is a publicly traded cannabis consumer platform with B2B retail tools and editorial content. It is comparable to Prohibition Partners as a cannabis media and data platform but serves consumers first rather than enterprise operators.

TypeDirect peer
Description

ICBC operates B2B cannabis conferences and policy summits in North America and Europe. It is directly comparable to Prohibition Partners' events arm and competes for the same European cannabis operator audience.

TypeDirect peer
Description

CannaTech is a global cannabis technology conference and media platform with summits across multiple geographies. It is directly comparable to Prohibition Partners' events and media business, particularly its Business of Cannabis summits.

TypeDirect peer
Description

New Cannabis Ventures publishes cannabis industry news, company profiles, and investor-focused intelligence. It is comparable to Prohibition Partners as a niche B2B intelligence and media platform targeting cannabis operators and investors.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Prohibition Partners

Cannabis Industry Intelligence and Consultingprohibitionpartners.com

Prohibition Partners is a London-based cannabis industry intelligence and events company founded in 2017, publishing market research (Global Medical Cannabis Market Review), operating media platforms (Business of Cannabis, Cannabis Health News), and running PPX growth marketing services for cannabis operators across global markets.

What Prohibition Partners does

Prohibition Partners is a London-based, privately held cannabis industry intelligence and events company founded in 2017, operating as a B2B research and media business serving cannabis operators, cultivators, manufacturers, dispensaries, insurers, and healthcare stakeholders across global markets including the UK, Germany, Canada, Australia, Brazil, Portugal, Poland, Thailand, and the Czech Republic. The company's product portfolio centers on the annual Global Medical Cannabis Market Review, which compiles export volumes, patient market sizes, telemedicine adoption, and regulatory developments, and is distributed alongside owned media platforms (Business of Cannabis, Cannabis Health News) that serve as both thought-leadership assets and top-of-funnel distribution channels. In February 2026 the company launched PPX, a full-service growth marketing division providing brand strategy, market entry, PR, and demand generation services to cannabis businesses, leveraging the company's proprietary market data and regulatory advisors to deliver compliant creative work that traditional agencies cannot provide. Revenue is generated through four streams: subscription and recurring intelligence reports, events and conferences (including the Business of Cannabis: New York Summit), PPX professional services engagements, and specialized risk analysis reports produced in partnership with Relm covering insurance challenges in the cannabis sector. Leadership is held by co-founders Stephen Murphy (CEO) and Rob Reid.

Prohibition Partners firmographics

Firmographics
Name
Prohibition Partners
Website
https://prohibitionpartners.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Prohibition Partners is a London-based cannabis industry intelligence and events company founded in 2017, publishing market research (Global Medical Cannabis Market Review), operating media platforms (Business of Cannabis, Cannabis Health News), and running PPX growth marketing services for cannabis operators across global markets.
Ownership category
akta.pro rank

Where Prohibition Partners is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

Prohibition Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

  1. Intelligence Reports and Research: Annual and periodic market intelligence publications covering global medical cannabis markets, trends, and regulatory analysis.
  2. Events and Conferences: Industry events including the Business of Cannabis: New York Summit, connecting operators and stakeholders in the cannabis industry.
  3. PPX Marketing Services: Full-service growth marketing division providing brand strategy, market entry, PR, and demand generation services to cannabis businesses.
  4. Risk Briefing Partnership Reports: Specialized insurance and risk analysis reports produced in partnership with Relm, targeting cannabis operators and insurers.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Prohibition Partners product offering

Product offering

Core offering

Prohibition Partners is a cannabis industry intelligence and events company that publishes market research reports, operates media platforms (Business of Cannabis, Cannabis Health News), and runs industry conferences focused on the legal cannabis sector. It also delivers growth marketing services through its PPX division, combining proprietary market data and regulatory expertise to serve cannabis operators across global markets.

Product overview

Prohibition Partners operates as a cannabis industry intelligence and events company offering a portfolio of products including industry research reports (Global Medical Cannabis Market Review, Risk Briefing), media platforms (Business of Cannabis, Cannabis Health News), and growth marketing services (PPX). The company provides market intelligence, regulatory analysis, and strategic services to cannabis businesses, leveraging its proprietary data and regulatory expertise across multiple markets.

Differentiator

Problem solved

Functional benefit

Brands

  • Business of Cannabis: Media platform covering cannabis industry news and market intelligence.
  • Cannabis Health News
  • PPX

Products and services

  • PPX Growth Marketing Division Full-service growth marketing division providing brand strategy, market entry, public relations, and demand generation services to cannabis businesses, leveraging proprietary market data and regulatory expertise.
  • Global Medical Cannabis Market Review Annual industry intelligence report providing analysis of the global medical cannabis market, including market sizing, trade flows, regulatory developments, and patient access trends across key markets such as Canada, Germany, UK, Australia, Brazil, and Portugal.
  • Business of Cannabis Media platform covering cannabis industry news, market analysis, and business intelligence, operated by Prohibition Partners and used as part of the PPX growth marketing ecosystem.
  • Cannabis Health News Health-focused media platform covering medical cannabis topics and information, operated by Prohibition Partners as part of its owned media ecosystem.
  • Risk Briefing Report Specialized risk management report published in partnership with Relm, providing analysis of insurance challenges, governance practices, EU-GMP certifications, and comprehensive risk controls for cannabis operators and insurers.
  • Business of Cannabis Industry Summits and Events Industry conferences and summits, including the Business of Cannabis: New York Summit, connecting cannabis operators, investors, and other stakeholders across the global cannabis industry.

Quantifiable outcome

  • Canada shipped 275,343kg in 2025, representing over 250% year-on-year growth
  • +3 more outcomes

Companies that use Prohibition Partners

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Prohibition Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Prohibition Partners partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • RelmcoreStrategic or Co-development PartnerPartnership with Relm to produce Risk Briefing reports analyzing insurance challenges in the cannabis industry. The collaboration resulted in a comprehensive report including interviews with operators such as Glass Pharms, Linnea, SOMAÍ Pharmaceuticals, and PHCANN International. The report addresses governance practices, EU-GMP certifications, and comprehensive risk controls that insurers are demanding from cannabis operators.
  • Business of CannabiscoreOthersOwned media platform serving as a primary distribution channel for Prohibition Partners' market intelligence and thought leadership. The platform provides news, analysis, and industry coverage supporting the company's intelligence and marketing services.
  • Cannabis Health NewscoreOthersOwned media platform focused on medical cannabis health content. Part of Prohibition Partners' owned media ecosystem that leverages proprietary market data and regulatory advisors to deliver compliant content.

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

Prohibition Partners competitors and assessment

Company assessment

Emerging players

  • The Dales Report: The Dales Report provides cannabis industry news, research, and educational content targeting operators and investors. It is an emerging peer to Prohibition Partners' Business of Cannabis and Cannabis Health News platforms, with a smaller footprint.

Direct peers

  • Green Market Report: Green Market Report is a cannabis-focused financial and business news outlet covering publicly traded cannabis companies and market trends. It overlaps with Prohibition Partners' intelligence and media offerings for the cannabis investment community.
  • Cannabis Business Times: Cannabis Business Times is a leading B2B trade publication covering cultivation, retail, and regulatory developments in the cannabis industry. It is directly comparable to Prohibition Partners' Business of Cannabis platform in serving cannabis operators with news and analysis.
  • MJBizDaily (MJBiz): MJBizDaily is the largest B2B cannabis media and events company in North America, running the flagship MJBizCon expo and a suite of market research reports. It is directly comparable to Prohibition Partners as a cannabis-focused intelligence, media, and events franchise serving operators.
  • International Cannabis Business Conference (ICBC): ICBC operates B2B cannabis conferences and policy summits in North America and Europe. It is directly comparable to Prohibition Partners' events arm and competes for the same European cannabis operator audience.
  • CannaTech: CannaTech is a global cannabis technology conference and media platform with summits across multiple geographies. It is directly comparable to Prohibition Partners' events and media business, particularly its Business of Cannabis summits.
  • New Cannabis Ventures: New Cannabis Ventures publishes cannabis industry news, company profiles, and investor-focused intelligence. It is comparable to Prohibition Partners as a niche B2B intelligence and media platform targeting cannabis operators and investors.

Broad incumbents

  • Weedmaps (WM Technology): Weedmaps is a publicly traded cannabis marketplace and SaaS platform serving retailers and brands with listings, advertising, and data. It overlaps with Prohibition Partners' PPX marketing services and intelligence offerings but is a larger, more diversified incumbent.
  • Benzinga Cannabis: Benzinga is a broader financial media company with a dedicated cannabis vertical covering market moves, M&A, and policy. It overlaps with Prohibition Partners' intelligence reporting for cannabis investors but operates at a much larger, more diversified scale.
  • Leafly Holdings: Leafly is a publicly traded cannabis consumer platform with B2B retail tools and editorial content. It is comparable to Prohibition Partners as a cannabis media and data platform but serves consumers first rather than enterprise operators.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

Prohibition Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Prohibition Partners leadership team

Management profile

Number of profiles

Profiles2 records

Prohibition Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Prohibition Partners M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prohibition Partners

What does Prohibition Partners do?

Prohibition Partners is a cannabis industry intelligence and events company that publishes market research reports, operates media platforms (Business of Cannabis, Cannabis Health News), and runs industry conferences focused on the legal cannabis sector. It also delivers growth marketing services through its PPX division, combining proprietary market data and regulatory expertise to serve cannabis operators across global markets.

Is Prohibition Partners a public or private company?

Prohibition Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Prohibition Partners founded?

Prohibition Partners was founded in 2017. It employs 11 to 50 people.

Where is Prohibition Partners based?

Prohibition Partners is headquartered in London, United Kingdom, in the Europe region.

How does Prohibition Partners make money?

Four revenue lines are on record. Intelligence Reports and Research is the primary driver. The others are events and Conferences, PPX Marketing Services and risk Briefing Partnership Reports.

Who are Prohibition Partners's main competitors?

The Dales Report is listed as an emerging player. Direct peers are Green Market Report, Cannabis Business Times, MJBizDaily (MJBiz), International Cannabis Business Conference (ICBC), CannaTech and New Cannabis Ventures. Broad incumbents are Weedmaps (WM Technology), Benzinga Cannabis and Leafly Holdings.

Does Prohibition Partners have an API?

No public API is recorded for Prohibition Partners.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsHeidi Whitman Joins Prohibition Partners as Managing Director for New Marketing Platform PPXHeidi Whitman was appointed Managing Director of PPX, a new marketing platform under Prohibition Partners, bringing over a decade of cannabis industry experience. PPX will offer advisory, media, and market intelligence services, with Whitman emphasizing compliance and ethics. She also co-founded the EmpowHer Cannabis Society, which now connects members across 40+ countries.PRESSBEEHeidi Whitman Welcomed as Managing Director for Prohibition Partners New Growth Marketing Platform PPX ...Middle EastHeidi Whitman has joined Prohibition Partners as Managing Director of PPX, a new growth marketing platform. The announcement was made on October 6, 2026, and the company pairs a decade of cannabis market infrastructure with her international network.AdvfnHeidi Whitman Welcomed as Managing Director for Prohibition Partners New Growth Marketing Platform PPXHeidi Whitman joined Prohibition Partners as Managing Director of PPX, a new growth marketing platform. She brings a decade of industry experience and a network of regulators, financiers, and formulators. Her goal for 2027 is to lead clients into regional and international markets and convene a female health symposium.PR NewswireHeidi Whitman Welcomed as Managing Director for Prohibition Partners New Growth Marketing Platform PPXHeidi Whitman joined Prohibition Partners as Managing Director of PPX, a new strategic pillar combining the company's cannabis market infrastructure with her international network. PPX will provide advisory, media, and investor introductions, with Whitman targeting 2027 growth across regional and international markets.CannabishealthnewsUK Medical Cannabis Patient Numbers Set to Reach 140,000 in 2026, Industry Report FindsUK medical cannabis patient numbers are projected to reach 140,000 by the end of 2026, nearly doubling from approximately 100,000 a year earlier, as imports more than doubled to 30,061 kg in 2025, according to a report by Prohibition Partners. Canada now supplies between 70% and 80% of all medical cannabis entering the UK, with exports rocketing 562% year-on-year to 17.07 tonnes, displacing Spain whose market share has collapsed from over 50% to just 11%. The rapid growth is being driven almost entirely through private online clinics, with just eight platforms accounting for an estimated 80% of prescriptions, prompting regulatory scrutiny from bodies including the Care Quality Commission.Prohibition PartnersFive Takeaways from the Global Medical Cannabis Market Review 2026Prohibition Partners published its Global Medical Cannabis Market Review 2026, identifying Canada as the dominant exporter with 275,343kg shipped in 2025, representing over 250% year-on-year growth. Germany emerged as the largest patient market outside North America at $997 million, growing 155% year-on-year following its 2024 cannabis deregulation, while the UK market doubled to $298 million. The report also notes that telemedicine has become the dominant patient access model across Australia, Germany, the UK, and Brazil, and that Portugal is shifting from a cultivation hub to a processing and re-exportation center.Business of CannabisWhy We Built PPX: From Advocacy to GrowthProhibition Partners, a cannabis industry intelligence and events company, has launched PPX as a new full-service growth marketing division to help cannabis businesses with brand strategy, market entry, PR, and demand generation. The company argues the new service fills a gap left by traditional agencies, which lack sector-specific regulatory expertise, real-time market intelligence, and access to institutional networks in the cannabis space. PPX will leverage Prohibition Partners' existing platforms, including Business of Cannabis and Cannabis Health News, along with proprietary market data and regulatory advisors to deliver compliant creative and growth marketing.Business of CannabisWhy Insurance Signals Maturity in the Cannabis SectorThe legal cannabis industry has historically faced significant challenges obtaining insurance coverage due to regulatory uncertainty, with operators in the UK and Europe experiencing bank account closures, coverage rejections, and fines. According to a newly published Risk Briefing by Relm in partnership with Prohibition Partners, insurance challenges are shifting from capital availability to operator professionalization, with insurers now demanding evidence of governance practices, EU-GMP certifications, and comprehensive risk controls. The report—which includes interviews with operators such as Glass Pharms, Linnea, SOMAÍ Pharmaceuticals, and PHCANN International—highlights that insurers are increasingly pushing cannabis operators toward best practices, with companies demonstrating how meeting underwriting requirements can drive operational maturity across the supply chain.Business of CannabisGlobal Cannabis Risk Briefing from Relm & Prohibition PartnersRelm Insurance, in collaboration with Prohibition Partners, released its inaugural Relm Risk Briefing: Cannabis 2026, a global report examining risk across the cannabis supply chain from cultivation through retail. The report draws on data, case studies, and interviews with operators and regulators across Europe, North America, and Canada, identifying recurring drivers of loss including contamination, quality failures, logistics disruption, and governance gaps. The briefing argues the cannabis sector has evolved from experimental markets to established commercial activity, with risk management and professional governance increasingly determining which operators can scale.CannabishealthnewsPrescribing, Products and Patient Access: What to Expect from Medical Cannabis in 2026Prohibition Partners analysts predict the global medical cannabis market will enter a more cautious phase in 2026, following stalled reforms in markets like the Czech Republic and US, and potential regression in Germany and Australia despite Trump's Executive Order rescheduling cannabis to Schedule III. Telemedicine restrictions are expected in Germany and possibly Australia due to concerns about recreational users accessing cannabis through these platforms, which analysts warn could significantly impact market size and patient access, particularly in rural areas. The report also forecasts tightening restrictions on raw flower products in Europe, steady growth in the UK market with increased regulatory scrutiny, and a broader shift in cannabis marketing from lifestyle branding toward medical and wellness positioning.